Life Science Investing RETRANSMISSION: Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins
Life Science Investing Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins
Life Science Investing Defence to Complete a Final Pre-Clinical Study Prior to IND Filings for the AccuTOX Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research Institute
Life Science Investing Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million
Element79 Gold Corp. Comments on Peruvian Government Reform Centralizing Oversight of Small-Scale Mining Under Ministry of Energy and Mines
Quimbaya Gold Reports High-Grade Rock Samples up to 11.21 g/t Au and 23.3 g/t Ag at Tahami South, Colombia
